Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Waserman
Wade Watson

Showing results (71-80 of 190) with videos related to

Pageof 19
Sort By:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 2, 2015
CSACI position statement: epinephrine auto-injectors and children < 15 kgMichelle Halbrich, Douglas P Mack, Stuart Carr, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 8, 2010
Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI)Eric Leith, Tom Bowen, Joe Butchey, et al.
Allergy and Asthma Proceedings|January 31, 2023
Epinephrine autoinjectors: individualizing device and dosage to optimize anaphylaxis management in the community settingHarold Kim, Reza Alizadehfar, Waleed Alqurashi, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 20, 2024
Non-immunoglobulin E-mediated food allergyVictoria E Cook, Lori A Connors, Timothy K Vander Leek, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 20, 2024
Eosinophilic esophagitisStephanie C Erdle, Stuart Carr, Edmond S Chan, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2004
The Canadian asthma primary prevention study: outcomes at 2 years of ageAllan Becker, Wade Watson, Alexander Ferguson, et al.
Advances in Therapy|February 13, 2024
Exploring Perceptions of Biologic Therapies: A Qualitative Study Among Canadians Living with Severe AsthmaAndrea Bever, Jessica Dunne, Jenna Reynolds, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2020
Multidisciplinary Real-World Experience With Bilastine, a Second Generation AntihistamineCharles W. Lynde, Gordon Sussman, Pierre-Luc Dion, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 20, 2015
Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitisHarold Kim, Susan Waserman, Jacques Hébert, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2009
Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactionsKatherine Arias, Moiz Baig, Marc Colangelo, et al.
Pageof 19

Showing results (71-80 of 190) with videos related to

Sort By:
Pageof 19
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 2, 2015
CSACI position statement: epinephrine auto-injectors and children < 15 kgMichelle Halbrich, Douglas P Mack, Stuart Carr, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 8, 2010
Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI)Eric Leith, Tom Bowen, Joe Butchey, et al.
Allergy and Asthma Proceedings|January 31, 2023
Epinephrine autoinjectors: individualizing device and dosage to optimize anaphylaxis management in the community settingHarold Kim, Reza Alizadehfar, Waleed Alqurashi, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 20, 2024
Non-immunoglobulin E-mediated food allergyVictoria E Cook, Lori A Connors, Timothy K Vander Leek, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 20, 2024
Eosinophilic esophagitisStephanie C Erdle, Stuart Carr, Edmond S Chan, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2004
The Canadian asthma primary prevention study: outcomes at 2 years of ageAllan Becker, Wade Watson, Alexander Ferguson, et al.
Advances in Therapy|February 13, 2024
Exploring Perceptions of Biologic Therapies: A Qualitative Study Among Canadians Living with Severe AsthmaAndrea Bever, Jessica Dunne, Jenna Reynolds, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2020
Multidisciplinary Real-World Experience With Bilastine, a Second Generation AntihistamineCharles W. Lynde, Gordon Sussman, Pierre-Luc Dion, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 20, 2015
Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitisHarold Kim, Susan Waserman, Jacques Hébert, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2009
Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactionsKatherine Arias, Moiz Baig, Marc Colangelo, et al.
Pageof 19